Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 18.1.2021 | EN | Official Journal of the European Union | C 19/63 |

---

Action brought on 13 November 2020 — Dr. August Wolff v EUIPO — Combe International (Vagisan)

(Case T-679/20)

(2021/C 19/68)

Language of the case: English

Parties

Applicant: Dr. August Wolff GmbH & Co. KG Arzneimittel (Bielefeld, Germany) (represented by: A. Thünken, lawyer)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: Combe International Ltd (New York, New York, United States)

Details of the proceedings before EUIPO

Proprietor of the trade mark at issue: Applicant before the General Court

Trade mark at issue: International registration designating the European Union in respect of the word mark Vagisan — International registration designating the European Union No 10 985 168

Procedure before EUIPO: Cancellation proceedings

Contested decision: Decision of the Fourth Board of Appeal of EUIPO of 3 September 2020 in Case R 2459/2019-4

Form of order sought

The applicant claims that the Court should:

|  |  |
| --- | --- |
| — | annul the contested decision; |

|  |  |
| --- | --- |
| — | annul the decision of the Cancellation Division of the EUIPO No 000018101 C of 11 September 2019, |

|  |  |
| --- | --- |
| — | order the EUIPO and, as the case may be, the intervener to bear the costs of the proceedings and the costs incurred by proceedings before the EUIPO. |

Plea in law

|  |  |
| --- | --- |
| — | Infringement of Article 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council. |

---

[Top](#document1)